An intra-oral, nanoemulsion blend is provided that enhances liver and toxin excretion performance in mammals when orally administered. A solid powder toxin binding composition also is provided that may be used to irreversibly bind the toxins reaching the bowel so that once the toxins are excreted into the bowel, they may not be reabsorbed, and are thus eliminated. A method of administering the nanoemulsion blend and the toxin binding composition to enhance toxin excretion also is described. The nanoemulsion blend is ingestible and edible.

The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswella sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.

The present invention provides compositions and methods for the treatment of skin lesions. In particular, embodiments of the invention provide topical compositions useful in the treatment and alleviation of cutaneous symptoms associated with psoriasis, dermatitis and other dermatological conditions including ulcers or lesions, wherein the compositions contain CBD oil.

The present invention provides compositions and methods for the treatment of skin lesions. In particular, embodiments of the invention provide topical compositions useful in the treatment and alleviation of cutaneous symptoms associated with psoriasis, dermatitis and other dermatological conditions including ulcers or lesions, wherein the compositions contain CBD oil.

The present invention provides compositions and methods for the treatment of skin lesions. In particular, embodiments of the invention provide topical compositions useful in the treatment and alleviation of cutaneous symptoms associated with psoriasis, dermatitis and other dermatological conditions including ulcers or lesions, wherein the compositions contain CBD oil.

The present invention is directed to a composition comprising a water-based extract of a Commiphora plant, and method of use thereof for preventing or treating an ultra-violate (UV) radiation damage to a subject's skin.

An acoustic device is configured to diagnose and treat tinnitus. The device includes a wearable support in the form of a headset, a pair of acoustic emitter-receivers, a pair of electromagnetic stimulation elements, an acoustic signals generator and an electromagnetic signals generator. The acoustic emitter-receivers and the electromagnetic stimulation elements are all are placed on the wearable support. The acoustic signals generator, which generates a diagnosis acoustic signal and a treatment acoustic signal to the acoustic emitter-receivers, is arranged on or associated with the wearable support. The electromagnetic signals generator, which induces microelectric signals to the electromagnetic stimulation elements, is also arranged on or associated with the wearable support.

An acoustic device is configured to diagnose and treat tinnitus. The device includes a wearable support in the form of a headset, a pair of acoustic emitter-receivers, a pair of electromagnetic stimulation elements, an acoustic signals generator and an electromagnetic signals generator. The acoustic emitter-receivers and the electromagnetic stimulation elements are all are placed on the wearable support. The acoustic signals generator, which generates a diagnosis acoustic signal and a treatment acoustic signal to the acoustic emitter-receivers, is arranged on or associated with the wearable support. The electromagnetic signals generator, which induces microelectric signals to the electromagnetic stimulation elements, is also arranged on or associated with the wearable support.